Medroxyprogesterone is a synthetic progestin derivative that mimics the action of natural progesterone. It is primarily used to treat conditions such as endometriosis and to provide contraception through suppression of ovulation. The medication works by binding to progesterone receptors in the uterus and other target tissues thereby modulating hormonal signaling. This binding suppresses the release of gonadotropin-releasing hormone which leads to reduced luteinizing hormone and follicle-stimulating hormone levels preventing follicular development and ovulation. The reduction in ovarian activity also alters the cervical mucus and endometrial lining making the environment less receptive to implantation and pregnancy. Overall the drug induces a hormonal environment that prevents conception while also decreasing estrogen-driven proliferative processes in the endometrium.

Medroxyprogesterone is a synthetic progesterone derivative used as a long-acting hormonal contraceptive. It is administered by intramuscular injection and provides contraceptive protection for up to three months. The drug works by suppressing the hypothalamic-pituitary-gonadal axis, which reduces the release of gonadotropins. Lower gonadotropin levels prevent follicular development and ovulation in most users. In addition, Medroxyprogesterone thickens cervical mucus, making it less permeable to sperm. It also alters the endometrium, rendering it less suitable for implantation of a fertilized egg. The sustained release of the medication maintains these effects throughout the dosing interval. Clinically, these actions provide reliable birth control while offering benefits such as reduced menstrual bleeding for many users.

Medroxyprogesterone is a synthetic form of the hormone progesterone used in certain contraceptives. Some people experience changes in menstrual bleeding patterns such as irregular spotting or amenorrhea. Weight gain can occur due to fluid retention or increased appetite. Mood changes including occasional depression or anxiety have been reported. Decreased bone mineral density may develop with long term use. Acne or headaches are also possible side effects.

Many users notice weight gain as a common side effect of Medroxyprogesterone injections. Some experience irregular spotting or bleeding between periods which can vary in intensity. Headaches and dizziness are reported by a portion of patients during treatment. Mood changes such as mood swings or depression may occur in certain individuals. Long term use has been associated with decreased bone mineral density which can affect bone health. Nausea and breast tenderness are also listed among possible adverse reactions.